Market capitalization | $514.08m |
Enterprise Value | $654.93m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 12.42 |
EV/Sales (TTM) EV/Sales | 2.56 |
P/S ratio (TTM) P/S ratio | 2.01 |
P/B ratio (TTM) P/B ratio | 1.01 |
Revenue growth (TTM) Revenue growth | 3.97% |
Revenue (TTM) Revenue | $255.85m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
13 Analysts have issued a Definitive Healthcare forecast:
13 Analysts have issued a Definitive Healthcare forecast:
Sep '24 |
+/-
%
|
||
Revenue | 256 256 |
4%
4%
|
|
Gross Profit | 165 165 |
2%
2%
|
|
EBITDA | 33 33 |
61%
61%
|
EBIT (Operating Income) EBIT | -18 -18 |
40%
40%
|
Net Profit | -364 -364 |
100%
100%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.
Head office | United States |
CEO | Kevin Coop |
Employees | 830 |
Founded | 2011 |
Website | www.definitivehc.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.